Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro
Sign Up to like & getrecommendations! Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-97658-w
Abstract: Effective vaccines are slowing the COVID-19 pandemic, but SARS-CoV-2 will likely remain an issue in the future making it important to have therapeutics to treat patients. There are few options for treating patients with COVID-19.… read more here.
Keywords: cov replication; probenecid inhibits; replication vivo; sars cov ... See more keywords